Our kinetics studies indicated that treatment with anti-CD20 prior to infection did not affect the induction phase of the CD8+ T cell response, indicating that B cells are not involved in the initial events that drive CD8+ T cell immunity during T. cruzi infection. Here, CD8A is linked to infection.